Supplementary Tables 1 and 2 from Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

<p>Supplementary Table 1 - Histomorphological characteristics of tumor samples taken prior to treatment (PRE), early during treatment (EDT) and on disease progression (PROG) in melanoma patients receiving anti-PD-1 therapy Supplementary Table 2 - Immune infiltrate flux from pretreatment value to early during treatment biopsies (fold change).</p>